Updated Jun 4, 2025, 1:32 AM UTC
Income Statement - Metric | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | FY 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | FY 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | FY 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | FY 2025 | Q1 2026 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenues (USD, thousands) | 171,135.00 | 172,448 | 179,212.00 | 183,882.00 | 188,334 | 723,876 | 187,267 | ||||||||||||||
Cost of Revenues (USD, thousands) | 17,392.00 | 64,524 | 17,804 | 19,987.00 | 19,798.00 | 19,604 | 77,193 | 19,227 | |||||||||||||
Gross Profit (USD, thousands) | 153,743.00 | 587,980 | 154,644 | 159,225.00 | 164,084.00 | 168,730 | 646,683 | 168,040 | |||||||||||||
Research and Development Expenses (USD, thousands) | 82,973.00 | 324,688 | 82,791 | 83,286.00 | 84,239 | 341,467 | 75,127 | ||||||||||||||
Sales and Marketing Expenses (USD, thousands) | 103,921.00 | 391,955 | 104,332 | 108,649.00 | 104,708.00 | 102,261 | 419,950 | 99,841 | |||||||||||||
General and Administrative Expenses (USD, thousands) | 34,797.00 | 141,334 | 33,690 | 36,222.00 | 36,270.00 | 45,819 | 152,001 | 36,976 | |||||||||||||
Total Operating Expenses (USD, thousands) | 221,691.00 | 857,977 | 220,813 | 236,022.00 | 224,264.00 | 232,319 | 913,418 | 211,944 | |||||||||||||
Loss from Operations (USD, thousands) | (67,948.00) | (269,997) | (66,169) | (60,180.00) | (63,589) | (266,735) | (43,904) | ||||||||||||||
Interest Income and Other Income (Expense), Net (USD, thousands) | 20,624 | 4,360 | 6,760.00 | 4,949.00 | 3,578 | 19,647 | 5,830 | ||||||||||||||
Interest Expense (USD, thousands) | (1,005.00) | (3,952) | (942) | (955.00) | (934.00) | (852) | (3,683) | (791) | |||||||||||||
Loss Before Provision for Income Taxes (USD, thousands) | (61,639.00) | (253,325) | (62,751) | (70,992.00) | (56,165.00) | (60,863) | (250,771) | (38,865) | |||||||||||||
Provision for Income Taxes (USD, thousands) | 759.00 | 3,705 | 971 | 1,197.00 | 1,161.00 | 1,436 | 4,765 | 1,153 | |||||||||||||
Net Loss (USD, thousands) | (62,398.00) | (63,722) | (72,189.00) | (57,326.00) | (62,299) | (255,536) | (40,018) | ||||||||||||||
Balance Sheet - Metric | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | FY 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | FY 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | FY 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | FY 2025 | Q1 2026 |
Cash and cash equivalents (USD, thousands) | 236,663 | 222,049 | 219,400 | 196,772 | 184,728 | 184,728 | 193,791 | ||||||||||||||
Marketable securities (USD, thousands) | 282,801 | 282,801 | 302,240 | 302,224 | 258,541 | 282,156 | 282,156 | 277,011 | |||||||||||||
Restricted cash (USD, thousands) | - | - | - | 455 | 316 | 136 | 136 | 289,136 | |||||||||||||
Accounts receivable, net (USD, thousands) | 88,327 | 88,327 | 99,773 | 65,066 | 66,892 | 87,567 | 87,567 | 68,076 | |||||||||||||
Prepaid expenses and other current assets (USD, thousands) | 51,925 | 51,925 | 50,004 | 53,194 | 48,837 | 46,154 | 46,154 | 49,329 | |||||||||||||
Total current assets (USD, thousands) | 659,716 | 659,716 | 674,066 | 640,339 | 571,358 | 600,741 | 600,741 | 588,496 | |||||||||||||
Property and equipment, net (USD, thousands) | 96,543 | 96,543 | 96,955 | 95,742 | 96,627 | 95,836 | 95,836 | 94,740 | |||||||||||||
Operating lease right-of-use assets (USD, thousands) | 181,731 | 181,731 | 182,296 | 182,261 | 177,626 | 166,545 | 166,545 | 164,810 | |||||||||||||
Other assets (USD, thousands) | 23,970 | 23,970 | 24,851 | 27,034 | 28,545 | 28,293 | 28,293 | 29,087 | |||||||||||||
Total assets (USD, thousands) | 961,960 | 961,960 | 978,168 | 945,376 | 891,415 | 891,415 | 877,133 | ||||||||||||||
Accounts payable (USD, thousands) | 6,907 | 6,907 | 12,895 | 13,834 | 12,606 | 9,922 | 9,922 | 7,942 | |||||||||||||
Accrued expenses and other current liabilities (USD, thousands) | 75,821 | 75,821 | 68,111 | 72,598 | 69,307 | 83,031 | 83,031 | 78,310 | |||||||||||||
Deferred revenue, current (USD, thousands) | 265,306 | 265,306 | 292,191 | 285,508 | 279,560 | 300,798 | 300,798 | 288,993 | |||||||||||||
Operating lease liabilities, current (USD, thousands) | 19,179 | 19,179 | 20,316 | 21,200 | 21,556 | 22,066 | 22,066 | 24,118 | |||||||||||||
Total current liabilities (USD, thousands) | 367,213 | 367,213 | 393,513 | 393,140 | 383,029 | 415,817 | 415,817 | 399,363 | |||||||||||||
Term loan, net (USD, thousands) | 43,618 | 43,618 | 42,380 | 41,142 | 39,291 | 39,291 | 38,053 | ||||||||||||||
Deferred revenue, noncurrent (USD, thousands) | 5,916 | 5,916 | 4,882 | 3,684 | 2,581 | 2,005 | 2,005 | 1,298 | |||||||||||||
Operating lease liabilities, noncurrent (USD, thousands) | 215,084 | 215,084 | 214,108 | 212,855 | 207,527 | 201,733 | 201,733 | 197,082 | |||||||||||||
Other liabilities (USD, thousands) | 3,733 | 3,733 | 3,388 | 2,638 | 1,845 | 5,046 | 5,046 | 5,033 | |||||||||||||
Total liabilities (USD, thousands) | 635,564 | 635,564 | 658,271 | 653,459 | 634,886 | 663,892 | 663,892 | 640,829 | |||||||||||||
Common stock (USD, thousands) | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||||||||||
Additional paid-in capital (USD, thousands) | 1,821,216 | 1,821,216 | 1,880,675 | 1,942,911 | 2,002,764 | 2,059,848 | 2,059,848 | 2,118,447 | |||||||||||||
Accumulated other comprehensive loss (USD, thousands) | (236) | (236) | (2,472) | (778) | (983) | (3,851) | (3,851) | 1,955 | |||||||||||||
Accumulated deficit (USD, thousands) | (1,494,586) | (1,494,586) | (1,558,308) | (1,650,218) | (1,762,513) | (1,828,476) | (1,828,476) | (1,884,100) | |||||||||||||
Total stockholders’ equity (USD, thousands) | 326,396 | 326,396 | 319,897 | 291,917 | 239,270 | 227,523 | 227,523 | 236,304 | |||||||||||||
Total liabilities and stockholders’ equity (USD, thousands) | 961,960 | 961,960 | 978,168 | 945,376 | 874,156 | 891,415 | 891,415 | 877,133 | |||||||||||||
Cash Flow - Metric | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | FY 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | FY 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | FY 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | FY 2025 | Q1 2026 |
Net loss (USD, thousands) | (62,398.00) | (257,030) | (63,722) | (72,189.00) | (57,326.00) | (62,299.00) | (255,536) | (40,018) | |||||||||||||
Net cash used in operating activities (USD, thousands) | (15,337.00) | (17,931) | (1,898) | - | - | - | 14,925 | 6,764 | |||||||||||||
Net cash provided by (used in) investing activities (USD, thousands) | - | - | - | - | - | - | (6,129) | 4,176 | |||||||||||||
Net cash provided by (used in) financing activities (USD, thousands) | - | - | - | - | (48,919.00) | - | (58,093) | (5,523) | |||||||||||||
Depreciation and amortization (USD, thousands) | 3,937.00 | 14,344 | 4,014 | 4,279.00 | 4,437.00 | 4,813.00 | 17,543 | 4,963 | |||||||||||||
Amortization of deferred contract acquisition costs (USD, thousands) | 6,001.00 | 21,972 | 6,087 | 6,406.00 | 6,696.00 | 6,718.00 | 25,907 | 6,691 | |||||||||||||
Stock-based compensation expense (USD, thousands) | 51,849.00 | 202,418 | 48,640 | 60,107.00 | 51,955.00 | 50,569.00 | 211,271 | 48,167 | |||||||||||||
Net accretion of discount on marketable securities (USD, thousands) | - | (3,391) | (1,831) | (1,725.00) | (1,090.00) | (864.00) | (5,510) | (736) | |||||||||||||
Non-cash lease expense (USD, thousands) | 4,092.00 | 18,090 | 4,452 | 4,436.00 | 4,640.00 | 4,439.00 | 17,967 | 4,540 | |||||||||||||
Amortization of discount on revolving credit facility and term loan issuance costs (USD, thousands) | 31.00 | 122 | 30 | 31.00 | 30.00 | 31.00 | 122 | 30 | |||||||||||||
Purchases of marketable securities (USD, thousands) | (34,821.00) | (319,133) | (70,484) | (36,642.00) | (59,502.00) | (67,820.00) | (234,448) | (34,055) | |||||||||||||
Maturities of marketable securities (USD, thousands) | 17,500.00 | 43,141 | 51,500 | 39,796.00 | 104,309.00 | 44,996.00 | 240,601 | 41,000 | |||||||||||||
Purchases of property and equipment (USD, thousands) | (500.00) | (7,721) | (1,002) | (1,690.00) | (1,372.00) | (1,505.00) | (5,569) | (638) | |||||||||||||
Capitalized internal-use software costs (USD, thousands) | (1,115.00) | (5,440) | (1,375) | (1,408.00) | (1,919.00) | (2,011.00) | (6,713) | (2,131) | |||||||||||||
Repurchases of common stock (USD, thousands) | - | - | - | - | (54,847.00) | - | (78,354) | (14,526) | |||||||||||||
Proceeds from exercise of stock options (USD, thousands) | 987.00 | 4,843 | 1,085 | 1,044.00 | 1,755.00 | 5,217.00 | 9,101 | 1,257 | |||||||||||||
Proceeds from employee stock purchase plan (USD, thousands) | 0.00 | 15,069 | 8,866 | 0.00 | 4,799.00 | 0.00 | 13,665 | 7,746 | |||||||||||||
Taxes paid related to net share settlement of equity awards (USD, thousands) | (3.00) | (10) | (4) | 0.00 | (1.00) | 0.00 | (5) | - | |||||||||||||
Effect of foreign exchange rates on cash, cash equivalents, and restricted cash (USD, thousands) | 2,257.00 | 389 | (1,302) | 1,120.00 | (474.00) | (1,846.00) | (2,502) | 3,799 | |||||||||||||
Net decrease in cash, cash equivalents, and restricted cash (USD, thousands) | (31,651.00) | (289,900) | (14,614) | (2,194.00) | (22,767.00) | (12,224.00) | (51,799) | 9,216 | |||||||||||||
Beginning of period cash, cash equivalents, and restricted cash (USD, thousands) | - | - | - | 236,663 | 236,663 | 236,663 | 236,663 | 184,864 | |||||||||||||
End of period cash, cash equivalents, and restricted cash (USD, thousands) | - | - | - | 219,855 | 197,088 | 184,864 | 184,864 | 194,080 | |||||||||||||
Allowance for expected credit losses (USD, thousands) | 3,140 | 3,140 | 199 | 372 | 1,025 | 3,190 | 3,190 | 1,027 | |||||||||||||
Revenue by Geography - Metric [Unit] | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | FY 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | FY 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | FY 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | FY 2025 | Q1 2026 |
U.S. Revenue [$ Million] | - | - | - | - | - | - | - | - | |||||||||||||
International Revenue [$ Million] | - | - | - | - | - | - | - | - | |||||||||||||
Total Revenue [$ Million] | - | - | - | - | - | - | - | - | |||||||||||||
U.S. Revenue Growth [% YoY] | - | - | - | 9% | - | - | - | - | |||||||||||||
International Revenue Growth [% YoY] | - | - | 14.5% | 12.3% | - | - | - | - |